WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone.
Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic.
Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid.
The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity.
Chinese military ready to boost ties with Indonesian counterpart: defense spokesperson
UN approves an updated cholera vaccine that could help fight a surge in cases
Women share the infuriating behaviour that made them start to rethink their relationships
Missouri lawmakers back big expansion of low
I know who killed Jill Dando, says her Crimewatch co
Barcelona to get floating desalination plant to help fight drought in northeastern Spain
Arkansas Supreme Court says new DNA testing can be sought in 'West Memphis 3' case
Man fleeing cops in western Michigan dies after unmarked cruiser hits him
Chinese defense minister holds video call with US counterpart
As earnings season rolls into its heart, hopes rise for broader gains
British and Irish officials meet as tensions rise over what to do with asylum seekers
Does a photo show US troops stationed in Taiwan’s Kinmen islands? — Radio Free Asia